Publications of U. Reichl

Ritter, J. B., Genzel, Y., & Reichl, U.Monitoring Energy Metabolism: The Challenge of Intracellular Metabolite Analysis of Mammalian Cells in CulturePresented at: 1st Max Planck Workshop on "Metabolomics"Magdeburg, Germany, April 4, 2006.

Schulze-Horsel, J., Bock, A., Genzel, Y., & Reichl, U.Mammalian cell culture for influenza vaccine production: physiology during cell growth and virus propagation phasePresented at: GVC/DECHEMA-Jahrestagungen 2006 mit 24. DECHEMA-Jahrestagung der BiotechnologenWiesbaden, Germany, September 24, 2006.

Wolff, M. W., Kalbfuss, B., Lehmann, S., Morenweiser, R., Opitz, L., Zimmermann, A., & Reichl, U.Downstream Processes and Glycan Characterization of MDCK-Cell Derived Influenza VirusPresented at: BioProcess Technology - AsiaSingapore, June 26, 2006.

Wolff, M. W., Kalbfuss, B., Opitz, L., Zimmermann, A., Lehmann, S., & Reichl, U.Downstream Process of Influenza VirusesPresented at: European BioPharm Scale-Up Congress 2006Geneva, Switzerland, September 12, 2006.

Genzel, Y., Schulze-Horsel, J., Möhler, L., Sidorenko, Y., & Reichl, U.Influenza Vaccines: Challenges in Mammalian Cell Culture TechnologyPresented at: 19th ESACT MeetingHarrogate, UK, June 5, 2005.

Heßeler, J., Schmidt, J. K., Reichl, U., & Flockerzi, D.How to achieve coexistence in the chemostat: a combined mathematical and experimental approachPresented at: European Conference on Mathematical and Theoretical Biology (ECMTB)Dresden, Germany, July 18, 2005.

Wolff, M., Kalbfuss, B., Morenweiser, R., Zimmermann, A., & Reichl, U.Chromatography-based Purification of Influenza A Virus for the Production of Human Whole-Virion VaccinesPresented at: Viral Vectors and Vaccines ConferenceAustin, Texas, November 14, 2005.

Wolff, M. W., Salaklang, J., Opitz, L., Schwarzer, J., Rapp, E., Kalbfuss, B., & Reichl, U.Development of a lectin-affinity chromatography step for the downstream processing of influenza virus vaccinesPresented at: AICHE Annual Meeting 2005Cincinnati, Ohio, USA, October 30, 2005.

Genzel, Y., König, S., & Reichl, U.Amino acid analysis in mammalian cell culture based virus vaccine production processesPresented at: IICS : 17th annual International Ion Chromatography SymposiumTrier, Germany, September 20, 2004.

Rapp, E., Lubda, D., Seidel-Morgenstern, A., Reichl, U., & Tallarek, U.Sheathless ESI-Interface for Coupling Capillary Separation Techniques to Mass SpectrometyPresented at: 37. Diskussionstagung der Deutschen Gesellschaft für MassenspektrometrieLeipzig, Germany, March 7, 2004.

Pelz, L., Dogra, T., Rüdiger, D., Boehme, J., Kershaw, O., Bruder, D., Kupke, S. Y., & Reichl, U.Defective Interfering Particles of Influenza A Virus As Broad-Spectrum AntiviralsPresented at: 33^rd Annual Meeting of the Society for Virology (GfV)Vienna (Austria), March 25, 2023.

Piasecka, J., Rüdiger, D., Küchler, J., Kupke, S. Y., & Reichl, U.Mechanisms of antiviral action of the influenza defective interfering particle “OP7”Presented at: 33^rd Annual Meeting of the Society for Virology (GfV)Vienna (Austria), March 25, 2023.

Alcalá Orozco, E. A., Fiebig, T., Mahour, R., Grote, V., Rexer, T., & Reichl, U.Development of a cell-free multi-enzyme cascade for the synthesis of CDP-glycerolPresented at: GlycoBioTec 2023Berlin, Germany, January 17, 2023.

Alcalá Orozco, E. A., Huber, N., Klamt, S., Rexer, T., & Reichl, U.Development of a cell-free enzymatic cascade for the synthesis of GDP-fucose - modeling and optimizationPresented at: GlycoBioTec 2023Berlin, Germany, January 17, 2023.

Dogra, T., Pelz, L., Rüdiger, D., Hein, M. D., Baelkner, M., Julia D. Boehme, J. D., Marichal-Gallardo, P., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccinationPresented at: 32^nd Annual Meeting of the Society for Virology (GfV)Ulm (Germany), March 28, 2023.

Dogra, T., Pelz, L., Rüdiger, D., Hein, M. D., Baelkner, M., Julia D. Boehme, J. D., Marichal-Gallardo, P., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccinationPresented at: 8^th European Congress of VirologyGdańsk (Poland), May 4, 2023.

Hoang Son, T., Lange, F., Rexer, T., & Reichl, U.Multi-gram-scale production of uridine nucleotide sugars by in-vitro multi-enzyme cascadesPresented at: GlycoBioTec 2023Berlin, Germany, January 17, 2023.

Hoang Son, T., Wormstall, S.-T., Rexer, T., & Reichl, U.Development of an in-vitro multi-enzyme cascade for the synthesis of uridine diphosphate N-acetylgalactosamine using a DoE approachPresented at: GlycoBioTec 2023Berlin, Germany, January 17, 2023.

Juárez-Osorio, M., Darr, A., Volckmar, J., Bruder, D., Rexer, T., & Reichl, U.Towards full control over protein glycosylation: in-vitro glycoengineering of influenza A virus hemagglutinin and SARS-CoV-2 spike proteinPresented at: GlycoBioTec 2023Berlin, Germany, January 16, 2023.

Küchler, J., Opitz, P., Kupke, S. Y., Genzel, Y., Benndorf, D., & Reichl, U.Absolute quantification of viral proteins during single-round replication of vaccine producer cell linesPresented at: 32^nd Annual Meeting of the Society for Virology (GfV) Ulm (Germany), March 28, 2023.